Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study

Table 2 Clinicopathological characters of two patient groups by number of CTCs

Number of CTCs	0 - 4	5 ≤	P value
Number of subjects	41	24
TNM: Stage			0.1586
Stage I	29	11
Stage II	4	2
Stage III	4	6
Stage IV	4	5
TNM: T category			0.2753
T1	26	10
T2	5	3
T3	5	4
T4	5	7
TNM: N category			0.0257 *
N0	27	12
N1	5	0
N2	4	2
N3	5	10
TNM: M category			0.2121
M0	37	19
M1	4	5
Main histological type			0.6844
Differentiated type	15	10
Undifferentiated type	26	14
Lymphatic invasion			0.3177
Lx	2	2
L0	25	10
L1	14	12
Venous invasion			0.1293
Vx	2	2
V0	26	9
V1-2	13	13
Surgery			0.2124
Curative resection	38	19
Non-curative resection	1	3
No resection	2	2
Postoperative chemotherapy			0.1672
Presence	15	13
Absence	26	11

ISSN: 1471-2407